• Press Release

Mount Sinai Health System Participates in White House Summit on Organ Transplant

  • New York, NY
  • (June 13, 2016)

Sander S. Florman, MD, Director of the Recanati/Miller Transplantation Institute at Mount Sinai, participated today in an Organ Summit hosted by the White House in Washington, DC, as part of an effort to build on the Obama administration’s previous accomplishments to improve outcomes for individuals waiting for organ transplants and improve support for living donors.

At the summit, senior administration officials converged with representatives from hospitals, universities, companies, foundations, and patient advocacy organizations to announce a new set of actions that will serve as another essential step towards increasing access to organ transplants and reducing the organ waiting list.   

Together with seven other academic medical centers, Mount Sinai Health System created a Blue Ribbon Advisory Panel committed to establishing a national clearinghouse of educational resources about transplant and living donation for patients, living donors and the interested public.  Making previously privately held resources available to the public, the goal of this Panel is to ensure informed transplant and living donation decision-making and equity in access to quality information to combat barriers that research suggests limits access to transplants.  

Resources will be made publicly available by the end of the summer of 2017.  

“The availability of organs for transplantation has been far exceeded by the need, while the waiting lists continue to grow at a staggering pace, so we must find ways to increase the donor supply and to encourage living donation,” says Dr. Florman.  “People’s lives literally depend on these efforts and so I commend President Obama and his administration for shining a spotlight on these issues.  I am proud to participate with leaders from government, industry, patient advocacy groups and my colleagues in the transplant community to improve donation.”

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the "Honor Roll" of best hospitals in America, ranked No. 15 nationally in the 2016-2017 "Best Hospitals" issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation's top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai's Kravis Children's Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.